

<!-- page 1 -->

w;s úfYI
wxl 2049$31 - 2017 foieïn¾ ui 14 jeks n%yiam;skaod - 2017'12'14
No. 2049/31  -  thursday,  december 14,  2017
EXTRAORDINARY
Y%S ,xld m%cd;dka;%sl iudcjd§ ckrcfha .eiÜ m;%h
The Gazette of the Democratic Socialist Republic of Sri Lanka
(Published by Authority)
PART I : SECTION (I) — GENERAL
Government Notifications
1a - PG 3819 - 507 (12/2017)
This Gazette Extraordinary can be downloaded from www.documents.gov.lk
                  
       
              
               
            
        
                  
     
         
             
         
               
            
               
               
            
               
        
                 
        
              
               
            
         
                  
L.d.b. 9/2016
THE  NATIONAL  MEDICINES  REGULATORY  AUTHORITY  ACT,  No.  5  OF  2015
reGuLatIONs made by the minister of health, Nutrition and Indigenous medicine under section 142 read with section 
118 of the National medicines regulatory authority act, No. 5 of 2015.
  dr. Rajitha SenaRatne,
  minister of health,
  Nutrition and Indigenous medicine.
colombo,
12
th december, 2017.
REGULATIONS
the National medicines regulatory authority (ceiling on Prices) regulations No. 2 of 2016 published in the Gazette 
Extraordinary No. 1989/61 of October 21, 2016 is hereby amended as follows :-
(1) by the substitution for regulation 1 thereof, of the following :-
“1. these regulations may be cited as the ceiling on Prices regulations, No. 6 of 2017 and shall come into operation 
on 14.12.2017 ”;

<!-- page 2 -->

I fldgi ( ^I& fPoh - YS% ,xld m%cd;dka;s%l iudcjd§ ckrcfha w;s úfYI .eiÜ m;%h - 2017'12'14
Part I : Sec. (I) - GAZETTE EXTRAORDINARY OF THE DEMOCRATIC SOCIALIST REPUBLIC OF SRI LANKA - 14.12.2017
2a
(2) by the substitution for regulation 4 thereof, of the following :-
“4. On and after the relevant date, no manufacturer, importer, trader, distributor, pharmacist, medical practitioner, 
medical institution including a private medical institution, pharmacy or person who or which is in possession of 
any scheduled drug set out in column II of the schedule hereto, for the purpose of sale shall sell such drug above 
the maximum retail Price (mrP) stipulated in the corresponding entry in column V thereof.”;
(3) by the substitution for regulation 5 thereof, of the following :-
“5. a manufacturer, importer, trader, distributor, pharmacist, medical practitioner, medical institution including a 
private medical institution, pharmacy or person who or which is in possession of a scheduled drug for the purpose 
of sale currently sells such drug at a price less than the mrP stipulated in the schedule may increase the existing 
price by only five per centum (5%) and shall maintain at such revised price.”;
(4) by the substitution for regulation 6 thereof, of the following :-
“6. the relevant mrP as set out in the schedule hereto or the current retail price, whichever is less, of each unit 
of item in the stock of scheduled drugs manufactured or available in the market, medical institution including a 
private medical institution, pharmacy or person who or which is in possession of such drug for the purpose of sale 
on the relevant date shall be printed or marked on its commercial package or label as expeditiously as practicable, 
so however, before the expiry of a period of Forty-five days from the relevant date.”;
(5) by the substitution for regulation 7 thereof, of the following :-
“7. Notwithstanding the provisions of regulation 6, the mrP of each unit shall be as set out in the schedule on and 
after the relevant date. the mrP set out in the schedule shall continue to be valid and effectual from the relevant 
date until revised.”;
(6) by the substitution for regulation 9 thereof, of the following :-
“9. any manufacturer, importer, trader, distributor, pharmacist, medical practitioner, medical institution including a 
private medical institution, pharmacy or person who or which is in possession of a scheduled drug for the purpose 
of sale and contravenes the provisions of these regulations commits an offence and shall be triable under part IV of 
the National medicines regulatory authority act, No. 5 of 2015.”;
(7) by the substitution for regulation 10 thereof, of the following :-
“10. It shall be the duty of every manufacturer, importer, trader, distributor, pharmacist, medical practitioner, medical 
institution including a private medical institution, pharmacy or person who or which is in possession of scheduled 
drugs for the purpose of sale, to display at every retail outlet the mrP of the scheduled drugs set out in the schedule 
hereto.”; and
(8) by the substitution for the schedule thereof, of the following :-
scheduLe
maXImum  retaIL  PrIces  OF  48  seLected  medIcINaL  PrOduct  FOrmuLatIONs
Column 
I
Column II 
Generic Name
Column III
Route of Administration/ 
Dosage forms
Column IV
Strength
Column V
Ceiling 
Maximum Price 
(SLR)
1 aLbeNdaZOLe tablet/ capsule 400mg 31.50
2 amOXIcILLIN+cLaVuLaNIc acId Oral suspension 156mg/ 5ml 301.88
amOXIcILLIN+cLaVuLaNIc acId tablet/ capsule 375mg 37.17
amOXIcILLIN+cLaVuLaNIc acId tablet/ capsule 625mg 63.00
amOXIcILLIN+cLaVuLaNIc acId Injection 1.2g 662.55

<!-- page 3 -->

I fldgi ( ^I& fPoh - YS% ,xld m%cd;dka;s%l iudcjd§ ckrcfha w;s úfYI .eiÜ m;%h - 2017'12'14
Part I : Sec. (I) - GAZETTE EXTRAORDINARY OF THE DEMOCRATIC SOCIALIST REPUBLIC OF SRI LANKA - 14.12.2017
3a
Column 
I
Column II 
Generic Name
Column III
Route of Administration/ 
Dosage forms
Column IV
Strength
Column V
Ceiling 
Maximum Price 
(SLR)
3 cLarIthrOmycIN tablet/ capsule 250mg 38.33
cLarIthrOmycIN tablet/ capsule 500mg 77.70
cLarIthrOmycIN Oral suspension 125mg/5ml 457.80
4 aZIthrOmycIN tablet/ capsule 250mg 39.48
aZIthrOmycIN tablet/ capsule 500mg 55.39
aZIthrOmycIN Oral suspension 200mg/ 5ml 183.75
5 ceFurOXIme tablet/ capsule 250mg 47.78
ceFurOXIme tablet/ capsule 500mg 76.23
6 dOXycycLIN tablet/ capsule 100mg 10.61
7 acIcLOVIr tablet/ capsule 200mg 38.85
8 cIPrOFLOXacIN tablet/ capsule 250mg 6.04
cIPrOFLOXacIN tablet/ capsule 500mg 8.93
9 LeVOFLOXacIN tablet/ capsule 250mg 25.41
LeVOFLOXacIN tablet/ capsule 500mg 42
10 cePhaLeXIN tablet/ capsule 250mg 8.61
cePhaLeXIN tablet/ capsule 500mg 15.75
cePhaLeXIN Oral suspension 125mg/5ml 278.25
11 ceFIXIme tablet/ capsule 100mg 24.15
ceFIXIme tablet/ capsule 200mg 44.84
ceFIXIme Oral suspension 100mg/5ml 362.25
12 amLOdIPINe tablet/ capsule 5mg 16.07
amLOdIPINe tablet/ capsule 10mg 22.37
13 dILtIaZem tablet/ capsule 30mg 2.84
dILtIaZem tablet/ capsule 60mg 9.35
dILtIaZem tablet/ capsule 90mg 22.47

<!-- page 4 -->

I fldgi ( ^I& fPoh - YS% ,xld m%cd;dka;s%l iudcjd§ ckrcfha w;s úfYI .eiÜ m;%h - 2017'12'14
Part I : Sec. (I) - GAZETTE EXTRAORDINARY OF THE DEMOCRATIC SOCIALIST REPUBLIC OF SRI LANKA - 14.12.2017
4a
Column 
I
Column II 
Generic Name
Column III
Route of Administration/ 
Dosage forms
Column IV
Strength
Column V
Ceiling 
Maximum Price 
(SLR)
14 LOsartaN POtassIum tablet/ capsule 25mg 7.72
LOsartaN POtassIum tablet/ capsule 50mg 10.82
15 LOsartaN + hct tablet/ capsule 62.5mg 20.42
16 eNaLaPrIL tablet/ capsule 5mg 6.30
eNaLaPrIL tablet/ capsule 10mg 10.61
17 ateNOLOL tablet/ capsule 25mg 3.15
ateNOLOL tablet/ capsule 50mg 4.62
ateNOLOL tablet/ capsule 100mg 13.65
18 NIFedIPINe – sustained release tablet/ capsule 20mg 3.89
19 cLOPIdOGreL tablet/ capsule 75mg 18.38
20 atOrVastatIN tablet/ capsule 10mg 11.71
atOrVastatIN tablet/ capsule 20mg 18.48
21 rOsuVastatIN tablet/ capsule 5mg 22.58
rOsuVastatIN tablet/ capsule 10mg 38.85
22 teLmIsartaN tablet/ capsule 20mg 10.71
teLmIsartaN tablet/ capsule 40mg 17.01
teLmIsartaN tablet/ capsule 80mg 31.92
23 asPIrIN tablet/ capsule 75mg 3.15
asPIrIN tablet/ capsule 100mg 5.57
24 metFOrmIN tablet/ capsule 500mg 4.15
metFOrmIN-sustained release tablet/ capsule 500mg 8.09
metFOrmIN tablet/ capsule 850mg 7.77
25 GLIbeNcLamIde tablet/ capsule 5mg 2.31
26 GLIcLaZIde tablet/ capsule 80mg 11.87
27 thyrOXINe tablet/ capsule 50mcg 6.41
thyrOXINe tablet/ capsule 100mcg 9.56
28 GLIPIZIde tablet/ capsule 5mg 8.30
29 IbuPrOFeN tablet/ capsule 200mg 1.16
IbuPrOFeN tablet/ capsule 400mg 3.89

<!-- page 5 -->

I fldgi ( ^I& fPoh - YS% ,xld m%cd;dka;s%l iudcjd§ ckrcfha w;s úfYI .eiÜ m;%h - 2017'12'14
Part I : Sec. (I) - GAZETTE EXTRAORDINARY OF THE DEMOCRATIC SOCIALIST REPUBLIC OF SRI LANKA - 14.12.2017
5a
Column 
I
Column II 
Generic Name
Column III
Route of Administration/ 
Dosage forms
Column IV
Strength
Column V
Ceiling 
Maximum Price 
(SLR)
30 dIcLOFeNac sOdIum tablet/ capsule 50mg 13.65
dIcLOFeNac sOdIum tablet/ capsule 100mg 15.86
31 dIcLOFeNac POtassIum tablet/ capsule 50mg 11.50
32 ParacetamOL tablet/ capsule 500mg 1.37
33 sOdIum VaLPrOate tablet/ capsule 200mg 9.45
34 rIsPerIdONe tablet/ capsule 1mg 8.30
rIsPerIdONe tablet/ capsule 2mg 9.71
35 OLaNZaPINe tablet/ capsule 5mg 10.50
OLaNZaPINe tablet/ capsule 10mg 21.84
36 carbamaZePINe tablet/ capsule 200mg 12.60
37 aLPraZOLam tablet/ capsule 0.25mg 6.83
aLPraZOLam tablet/ capsule 0.5mg 10.40
38 FLuOXetINe tablet/ capsule 20mg 11.55
39 GabaPeNtIN tablet/ capsule 100mg 17.59
GabaPeNtIN tablet/ capsule 300mg 34.81
40 becLOmethasONe dP capsule (inhalation) 200mcg 6.30
becLOmethasONe dP capsule (inhalation) 400mcg 7.14
becLOmethasONe metered dose inhaler (200 
doses) 100mcg 532.88
becLOmethasONe metered dose inhaler (200 
doses) 250mcg 589.05
41 saLbutamOL dP capsule (inhalation) 200mcg 4.20
saLbutamOL dP capsule (inhalation) 400mcg 5.78
saLbutamOL metered dose inhaler (200 
doses) 100mcg 325.50
42 methyL PredNIsOLONe tablet/ capsule 4mg 12.44
methyL PredNIsOLONe tablet/ capsule 16mg 43.05
43 OmePraZOLe tablet/ capsule 20mg 4.73
44 PaNtOPraZOLe tablet/ capsule 20mg 17.85
PaNtOPraZOLe tablet/ capsule 40mg 29.40
45 esOmePraZOLe tablet/ capsule 20mg 21.21
esOmePraZOLe tablet/ capsule 40mg 40.32

<!-- page 6 -->

I fldgi ( ^I& fPoh - YS% ,xld m%cd;dka;s%l iudcjd§ ckrcfha w;s úfYI .eiÜ m;%h - 2017'12'14
Part I : Sec. (I) - GAZETTE EXTRAORDINARY OF THE DEMOCRATIC SOCIALIST REPUBLIC OF SRI LANKA - 14.12.2017
6a
Column 
I
Column II 
Generic Name
Column III
Route of Administration/ 
Dosage forms
Column IV
Strength
Column V
Ceiling 
Maximum Price 
(SLR)
46 dOmPerIdONe tablet/ capsule 10mg 5.67
47 rabePraZOLe tablet/ capsule 10mg 11.87
rabePraZOLe tablet/ capsule 20mg 22.63
48 aLeNdrONIc acId tablet/ capsule 70mg 106.47
PrINted  at  the  dePartmeNt  OF  GOVerNmeNt  PrINtING,  srI  LaNka.
12-1045